Ramsay Health Care Ltd (ASX: RHC) Share Price and News

Price

 

Movement

   

  (20 mins delayed)

52 Week Range

  -  

 
1 Year Return

 

Ramsay Health Care Limited Chart and Price Data

Fundamentals Data provided by Morningstar.

Data provided by Morningstar.
Market Cap $16.04 billion
P/E Ratio 36.36
Dividend Yield 2.16%
Shares Outstanding 228.88 million
Earnings per share 1.024
Dividend per share 2.06
Year To Date Return 15.11%
Earnings Yield 2.75%
Franking 100%
Share Price

Day Change

52 Week Range

-

Yesterday's Close

Today's Open

Days Range

-

Volume

Avg. Volume (1 month)

Turnover

as at 24 Feb 3:44pm

Should you invest $1,000 in right now?

Before you consider , you’ll want to hear this.

Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and wasn’t one of them.

The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.

*Returns as of August 16th 2021

Ramsay Health Care Ltd (ASX: RHC)
Latest News

Dividend Payment History Data provided by Morningstar.

Data provided by Morningstar.
Ex-Date Amount Franking Type Payable
06 Sep 2021 $1.0300 100.00% Final 30 Sep 2021
08 Mar 2021 $0.4850 100.00% Interim 31 Mar 2021
05 Mar 2020 $0.6250 100.00% Interim 27 Mar 2020
05 Sep 2019 $0.9150 100.00% Final 30 Sep 2019
06 Mar 2019 $0.6000 100.00% Interim 29 Mar 2019
05 Sep 2018 $0.8650 100.00% Final 28 Sep 2018
06 Mar 2018 $0.5750 100.00% Interim 29 Mar 2018
05 Sep 2017 $0.8150 100.00% Final 28 Sep 2017
07 Mar 2017 $0.5300 100.00% Interim 29 Mar 2017
06 Sep 2016 $0.7200 100.00% Final 29 Sep 2016
08 Mar 2016 $0.4700 100.00% Interim 30 Mar 2016
04 Sep 2015 $0.6050 100.00% 24 Sep 2015
05 Mar 2015 $0.4050 100.00% 26 Mar 2015
08 Sep 2014 $0.5100 100.00% Final 24 Sep 2014
04 Mar 2014 $0.3400 100.00% Interim 26 Mar 2014
03 Sep 2013 $0.4150 100.00% Final 25 Sep 2013
04 Mar 2013 $0.2900 100.00% Interim 27 Mar 2013
05 Mar 2012 $0.2550 100.00% Interim 28 Mar 2012
02 Sep 2011 $0.2950 100.00% Final 26 Sep 2011
08 Mar 2011 $0.2250 100.00% Interim 28 Mar 2011
31 Aug 2010 $0.2500 100.00% Final 27 Sep 2010
16 Mar 2010 $0.1850 100.00% Interim 09 Apr 2010
21 Sep 2009 $0.2150 100.00% Final 09 Oct 2009
20 Mar 2009 $0.1650 100.00% Interim 08 Apr 2009

RHC ASX Announcements

An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.

DateAnnouncementPrice Sensitive?TimeNo. of PagesFile Size
YesNo

About Ramsay Health Care Ltd

Ramsay Health Care Limited (RHC) is a global healthcare company that operates 221 hospitals and 14 day surgery centres, treatment facilities, rehabilitation and psychiatric units and a nursing college across Australia, United Kingdom, France, Indonesia, Malaysia and Italy.

Established in Sydney, Australia, in 1964, Ramsay Health Care has more than 50 years of experience in providing acute health care services. RHC made its ASX debut in 1997 and the Ramsay share price has gone from strength to strength since.

Today, Ramsay employs more than 77,000 staff and delivers a range of acute and primary healthcare services from 480 facilities across 11 countries, making it one of the largest and most diverse private healthcare companies in the world.

RHC Share Price History Data provided by Morningstar.

Data provided by Morningstar.
Date Close Change % Change Volume Open High Low
17 Sep 2021 $70.06 $0.68 0.98% 920,491 $69.58 $70.50 $69.41
16 Sep 2021 $69.38 $1.23 1.80% 762,218 $68.82 $69.53 $68.36
15 Sep 2021 $68.15 $0.12 0.18% 672,980 $67.97 $68.82 $67.09
14 Sep 2021 $68.03 $-0.57 -0.83% 552,651 $68.25 $68.39 $67.18
13 Sep 2021 $68.60 $0.18 0.26% 311,654 $68.14 $68.94 $67.83
10 Sep 2021 $68.42 $0.12 0.18% 518,334 $68.59 $68.90 $67.92
09 Sep 2021 $68.30 $-0.36 -0.52% 946,888 $68.51 $68.67 $67.80
08 Sep 2021 $68.66 $-1.09 -1.56% 354,388 $69.03 $69.45 $68.17
07 Sep 2021 $69.75 $-0.56 -0.80% 614,218 $70.17 $70.55 $69.28
06 Sep 2021 $70.31 $-1.64 -2.28% 911,322 $70.50 $70.65 $69.81
03 Sep 2021 $71.95 $2.18 3.12% 1,340,134 $70.25 $72.41 $69.64
02 Sep 2021 $69.77 $0.80 1.16% 1,079,173 $69.60 $70.07 $68.83
01 Sep 2021 $68.97 $0.07 0.10% 406,816 $68.66 $69.13 $67.59
31 Aug 2021 $68.90 $-0.16 -0.23% 710,863 $69.38 $69.64 $68.89
30 Aug 2021 $69.06 $0.85 1.25% 564,366 $67.99 $69.44 $67.46
27 Aug 2021 $68.21 $0.43 0.63% 404,017 $68.23 $69.19 $67.80
26 Aug 2021 $67.78 $1.18 1.77% 1,063,281 $66.20 $68.35 $65.38
25 Aug 2021 $66.60 $-0.38 -0.57% 407,785 $67.29 $67.36 $66.36
24 Aug 2021 $66.98 $-0.17 -0.25% 372,924 $66.86 $67.60 $66.70
23 Aug 2021 $67.15 $0.95 1.44% 371,300 $66.94 $67.28 $66.72
20 Aug 2021 $66.20 $-0.34 -0.51% 479,419 $66.72 $67.14 $66.01

Director Transactions Data provided by Morningstar.

Data provided by Morningstar.
Date Director Type Amount Value Notes
03 Sep 2021 Karen Penrose Issued 580 $39,996
Employee Share Ownership Plan/Directors Salary Sacrifice. 580 - Share Rights
Average price/VWAP
31 Aug 2021 Craig McNally Expiry 90 $6,223,392
As advised by the company. 106,046 - Performance Rights
90,325 Performance Rights granted under the Executive Performance Rights Plan failed to vest and therefore lapsed on 31 August 2021.
15 Dec 2020 Craig McNally Issued 55 $3,522,694
Issue of securities. 244,639 - Performance Rights
15 Dec 2020 Craig McNally Expiry 48 $3,060,191
As advised by the company. 196,371 - Performance Rights
lapsed.

Directors & Management Data provided by Morningstar.

Data provided by Morningstar.
Name Title Start Date Profile
Mr Peter John Evans Non-Executive DirectorNon-Executive Deputy Chairman Dec 1990
Mr Evans began working with Ramsay Health Care in 1969. He is a Chartered Accountant who was in public practice for over 20 years with predecessor firms of KPMG. Mr Evans has specialised in the financial management of hospitals and has had experience in the health care field for 50 years. Mr Evans is also a Trustee of the Paul Ramsay Foundation and has been involved with several other charitable organisations over many years. He is member of Risk Management committee.
Mr David Ingle Thodey Non-Executive Director Nov 2017
Mr Thodey is a business leader who has had a executive career in the technology and telecommunications industries, with more than 30 years of experience creating brand and shareholder value. In addition to being a Non-Executive Director and Lead Independent Director of Ramsay Health Care, Mr Thodey is currently Chairman of Australia's national scientific research agency, the Commonwealth Scientific and Industrial Research Organisation (CSIRO), Chairman of Tyro Payments Limited (a leading alternative payments provider) and Xero Limited (a small business accounting software company). Mr Thodey also had a successful career as CEO of Telstra, Australia's leading telecommunications and information services company, and prior to that he was CEO of IBM. Mr Thodey was awarded an Order of Australia in 2017 for his service to business and the promotion of ethical leadership and workplace diversity. In the past three years, Mr Thodey has served as a Director of the following listed companies: Xero Limited (Appointed June 2019), Tyro Payments Limited (Appointed November 2018) and Vodafone Group Plc (Resigned July 2020). He is chairman of Governance Committee and member of People Committee.
Ms Catriona Alison Deans Non-Executive Director Nov 2018
Ms Deans has 25 years experience building technology-enabled businesses involved in media, ecommerce, financial services and health, and across leadership roles as an executive, a director and in venture capital. Ms Deans joined the Board of Ramsay Health Care in November 2018. She is also a Non-Executive Director of Westpac Banking Corporation, Cochlear Limited, SCEGGS Darlinghurst and Deputy Pty Ltd. She is also on the Investment Committee of MainSequence Ventures. In her executive career Ms Deans was previously the CEO of eBay Australia and New Zealand, CEO of eCorp Limited, (a publicly listed portfolio of digital businesses), CEO of Hoyts Cinemas, and most recently CEO of netus Pty Ltd - a technology investment company acquired by Fairfax. Ms Deans also spent seven years as a Consultant with McKinsey & Company and is currently a Senior Advisor with the firm. In the past three years, Ms Deans has served as a Director of the following listed companies: Cochlear Limited (Appointed February 2015), Westpac Banking Corporation (Appointed April 2014) and Insurance Australia Group Limited (Resigned October 2017). She is member of People Committee and Governance Committee.
Mr Michael Stanley Siddle Non-Executive DirectorNon-Executive Chairman May 1975
Mr Siddle has experience in the management of private hospitals and has been integrally involved in Ramsay Health Care's successful expansion through construction, mergers and acquisitions. Mr Siddle is also a Trustee of the Paul Ramsay Foundation. He is member of People and Governance committee.
Mr Craig Ralph McNally Chief Executive OfficerManaging Director Jul 2017
Mr McNally was an executive of a private hospital in Sydney following completion of a health administration degree at the University of New South Wales.
Ms Karen Lee Collett Penrose Non-Executive Director Mar 2020
Ms Penrose has had an executive career in leadership and CFO roles, mainly in financial services. She is well-versed in financial management, customer outcomes and operating in a rapidly changing regulatory environment which stems from 20 years in banking with Commonwealth Bank and HSBC and eight years as a listed-company CFO. Ms Penrose also serves as a Director of Vicinity Centres, Bank of Queensland, and Estia Health. Ms Penrose is a member of Chief Executive Women and on the Board of Marshall Investments Pty Limited. In the past three years, Ms Penrose has served as a Director of the following listed companies: Vicinity Centres (Appointed June 2015), Bank of Queensland (Appointed November 2015), Estia Health (Appointed October 2018), Spark Infrastructure Group (Resigned May 2020), Future Generation Global Investment Company Limited (Resigned October 2018) and AWE Limited (Resigned April 2018). She is member of Risk Management Committee.
Ms Claudia Ricarda Rita Sussmuth Dyckerhoff Non-Executive Director Oct 2018
Dr Dyckerhoff has global experience in hospitals and health care across Europe, Asia, and the USA. She joined McKinsey & Company in Switzerland in 1995 and was transferred to the USA focusing on supporting health care companies, including pharmaceutical/medical device companies, payor, provider and health systems in Europe and the USA. In 2006, Dr Dyckerhoff transferred to China, was elected Senior Partner in 2010 and supported health care companies as well as governments across Asia. She also led McKinsey's Asia-wide Health Systems and Services Sector. Dr Dyckerhoff also supports three start-ups, and in September 2017 she joined the Board of med tech start-up Cyrcadia. In the past three years, Dr Sussmuth Dyckerhoff has served as a Director of the following listed companies: Hoffmann La Roche (Appointed March 2016) and Clariant AG (Appointed April 2016). She is member of Risk Management Committee
Mr James Malcolm McMurdo Non-Executive Director Sep 2019
Mr McMurdo has over 30 years finance and banking experience. He has a background in corporate advisory spanning across mergers and acquisitions, strategic advisory and financing with experience across multiple industries including the healthcare sector. He has held senior operating management roles and worked in both the Asia Pacific and European regions. Until July 2020, Mr McMurdo was Vice Chairman of Investment Banking for Deutsche Bank based in Hong Kong. He has held senior management roles at Deutsche Bank including Global Co-Head of Corporate Finance, Head of Corporate and Investment Bank for Asia Pacific and CEO for Australia and New Zealand. He sat on the firm's Global Executive Committee for the Corporate and Investment Bank for four years. Prior to this, Mr McMurdo was a Partner at Goldman Sachs where he held senior positions in the Investment Banking Division in Australia and Europe.
Ms Henrietta Rowe Company SecretaryGroup General Counsel Jun 2019
-
Daniel Sims CEO Ramsay Australia
-
Henrietta Rowe Company SecretaryGroup General Counsel
-
Martyn Roberts Group Chief Financial Officer
-
Olivier Chretien Group Chief Strategy Officer
-

Top Shareholders Data provided by Morningstar.

Data provided by Morningstar.
Name Shares Capital
Hsbc Custody Nominees (Australia) Limited 53,909,722 23.55%
Paul Ramsay Holdings Pty Limited 42,999,269 18.79%
J P Morgan Nominees Australia Pty Limited 33,404,461 14.59%
Citicorp Nominees Pty Limited 13,175,972 5.76%
National Nominees Limited 8,265,947 3.61%
BNP Paribas Nominees Pty Ltd <Agency Lending Drp A/C> 3,863,144 1.69%
Woolwich Investments Pty Ltd <The Siddle Family Trust> 3,750,000 1.64%
BNP Paribas Nominees Pty Ltd <DRP> 3,236,785 1.41%
Custodial Services Limited <Beneficiaries Holding A/C> 2,448,055 1.07%
Argo Investments Limited 2,023,131 0.88%
Australian Foundation Investment Company Limited 2,020,000 0.88%
Sargon Ct Pty Limited 2,010,406 0.88%
Netwealth Investments Limited <Wrap Services A/C> 1,083,872 0.47%
Citicorp Nominees Pty Limited <Colonial First State Inv A/C> 951,540 0.42%
HSBC Custody Nominees (Australia) Limited <NT Comnwlth Super Corp A/C> 899,255 0.39%
BNP Paribas Nominees Pty Ltd HUB24 Custodial Services Limited <DRP> 597,717 0.26%
BNP Paribas Nominees (NZ) Pty Ltd <DRP> 521,714 0.23%
Australian Executor Trustees Limited <IPS Super A/C> 513,494 0.22%
HSBC Custody Nominees (Australia) Limited i 473,717 0.21%
BKI Investment Company Limited 438,535 0.19%

Profile

since

Note